At a glance
ClinicalIndex Comparison RecordN/ACompleted· 255 enrolled
Drug / intervention
Inflectra +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Characteristics and 6-month Outcomes Among Real-World Rheumatoid Arthritis Patients Initiating Inflectra
In Brief
An observational study evaluating Inflectra for Arthritis, Rheumatoid. Completed, enrolled 255 participants across 1 site.
Detailed Summary
This is a retrospective observational study looking at the characteristics and outcomes of participants taking Inflectra using the CorEvitas Rheumatoid Arthritis Registry.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis, Rheumatoid
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedMay 2022
Enrollment StartNov 2022
Primary CompletionNov 2022
TodayJul 2026
First PostedMay 17, 2022
Enrollment StartNov 11, 2022
Primary CompletionNov 11, 2022
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 4.1 years ago
Interventions
Inflectradrug
1\. To describe the characteristics of patients newly initiated on Inflectra.
Inflectradrug
2\. To describe 6-month outcomes after initiating Inflectra, among patients who have 6 months follow-up information in the CorEvitas' RA Registry.